Guardant Health Shares Surge as UnitedHealthcare Covers Shield Blood Test
UnitedHealthcare will begin reimbursing Guardant Health’s Shield colorectal cancer blood test from August 1, driving strong investor reaction and broader commercial access.
UnitedHealthcare will begin reimbursing Guardant Health’s Shield colorectal cancer blood test from August 1, driving strong investor reaction and broader commercial access.
Can-Fite’s Namodenoson met safety endpoint and showed encouraging survival signals in Phase 2a pancreatic cancer study, including median OS >5 months in third-line patients and one survivor over 18 months.
The deal boosts Alcoa’s production by over 50% and delivers $900M in synergies.
China’s top EV makers delivered mixed results in June 2026. NIO and XPeng achieved strong year-over-year growth, while Li Auto saw sales drop for the second straight month.
General Mills topped Wall Street forecasts in Q4 with higher pricing and steady demand. Adjusted EPS hit 95 cents vs 80 cents expected.
Meta is developing a new cloud offering to monetize its massive AI infrastructure, selling GPUs, servers, and Llama models to external customers.